Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × anlotinib × 30 days × Clear all

Sponsor

Conditions

Thyroid Neoplasms 2 Whole-Brain Radiotherapy 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Leiomyosarcoma 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 7 Cisplatin 6 Paclitaxel 5 Drug Therapy 3 toripalimab 2 Radiotherapy 2 Irinotecan 2 Fluorouracil 2 Carboplatin 2 tislelizumab 1 regorafenib 1 osimertinib 1 nimotuzumab 1 lenvatinib 1 aflibercept 1 Oxaliplatin 1 Nivolumab 1 NEO212 1 Levoleucovorin 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Fulvestrant 1 Docetaxel 1 Dexamethasone 1 Chemoradiotherapy 1 Bevacizumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡